InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Zenitas Healthcare Limited (ASX: ZNT) - Announcements

DELISTED - Current share price for ZNT : $1.440

ASX company news and announcements for Zenitas Healthcare Limited (ZNT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Zenitas Healthcare Limited (ZNT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Zenitas Healthcare Limited (ZNT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Zenitas Healthcare Limited (ZNT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change of Director's Interest Notice 28 Feb 2018 10:31AM $1.220 $1.440 risen by 18.03%
- Change of Director's Interest Notices x2 27 Feb 2018 6:27PM $1.200 $1.440 risen by 20%
- Half Year Results Presentation 27 Feb 2018 9:14AM $1.140 $1.440 risen by 26.32%
- Dividend/Distribution - ZNT 27 Feb 2018 9:09AM $1.140 $1.440 risen by 26.32%
- Half Year Results Release 27 Feb 2018 9:04AM $1.140 $1.440 risen by 26.32%
- Appendix 4D and Half Year Report 27 Feb 2018 8:59AM $1.140 $1.440 risen by 26.32%
- APPOINTMENT/RESIGNATION OF COMPANY SECRETARY 23 Feb 2018 10:31AM $1.150 $1.440 risen by 25.22%
- Appendix 3B 22 Feb 2018 10:00AM $1.180 $1.440 risen by 22.03%
- Appendix 3B - exercise of options 19 Feb 2018 9:38AM $1.150 $1.440 risen by 25.22%
- Appendix 3B - exercise of options 12 Feb 2018 11:53AM $1.175 $1.440 risen by 22.55%
- Appendix 3B - exercise of options 6 Feb 2018 11:03AM $1.160 $1.440 risen by 24.14%
- Appendix 3B - exercise of unlisted options 1 Feb 2018 3:47PM $1.240 $1.440 risen by 16.13%
- Appendix 4C - quarterly 31 Jan 2018 11:47AM $1.240 $1.440 risen by 16.13%
- NOTICE UNDER ASX LISTING RULE 3.10A 18 Jan 2018 4:12PM $1.285 $1.440 risen by 12.06%
- AGEWELL PHYSIOTHERAPY ACQUISITION 22 Dec 2017 3:54PM $1.180 $1.440 risen by 22.03%
- PENINSULA SPORTS MEDICINE GROUP ACQUISITION 21 Dec 2017 11:04AM $1.180 $1.440 risen by 22.03%
- Appendix 3X - Dr Jonathan Seah 7 Dec 2017 9:19AM $1.200 $1.440 risen by 20%
- Non-Executive Director Appointed 7 Dec 2017 9:18AM $1.200 $1.440 risen by 20%
- Appendix 3B - exercise of unlisted options 6 Dec 2017 3:31PM $1.210 $1.440 risen by 19.01%
- Change of Directors Interest Notice 24 Nov 2017 11:33AM $1.210 $1.440 risen by 19.01%
- Change in substantial holding 24 Nov 2017 8:23AM $1.200 $1.440 risen by 20%
- Completion of Capital Raising 22 Nov 2017 3:04PM $1.200 $1.440 risen by 20%
- Completion of Retail Entitlement Offer 17 Nov 2017 12:21PM $1.195 $1.440 risen by 20.50%
- Becoming a substantial holder 14 Nov 2017 8:38AM $1.210 $1.440 risen by 19.01%
- Appendix 3B Cleaning Notice and LR3.10.5A disclosure 9 Nov 2017 8:28AM $1.230 $1.440 risen by 17.07%

51 - 75 of 140 results

Page 3 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.